Bio Impact Capital LLC has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $641 Million distributed in 43 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $128M, Insmed Inc with a value of $44.9M, Olema Pharmaceuticals, Inc. with a value of $32M, Avidity Biosciences, Inc. with a value of $31.6M, and Crinetics Pharmaceuticals, Inc. with a value of $26.9M.

Examining the 13F form we can see an increase of $18.3M in the current position value, from $623M to 641M.

Bio Impact Capital LLC is based out at Cambridge, MA

Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $641 Million
Healthcare: $641 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 43
  • Current Value $641 Million
  • Prior Value $623 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 10 stocks
  • Additional Purchases 20 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.